BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12845531)

  • 1. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.
    Peters G; Gongoll S; Langner C; Mengel M; Piso P; Klempnauer J; Rüschoff J; Kreipe H; von Wasielewski R
    Virchows Arch; 2003 Aug; 443(2):139-45. PubMed ID: 12845531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
    Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
    Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
    Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
    Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer.
    Shiratsuchi I; Akagi Y; Kawahara A; Kinugasa T; Romeo K; Yoshida T; Ryu Y; Gotanda Y; Kage M; Shirouzu K
    Anticancer Res; 2011 Jul; 31(7):2541-5. PubMed ID: 21873172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer.
    Huang F; Xu LA; Khambata-Ford S
    Clin Cancer Res; 2012 Feb; 18(4):1156-66. PubMed ID: 22294722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
    Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
    BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
    Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
    Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.
    Li ZJ; Ying XJ; Chen HL; Ye PJ; Chen ZL; Li G; Jiang HF; Liu J; Zhou SZ
    World J Gastroenterol; 2013 Nov; 19(43):7788-94. PubMed ID: 24282367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
    Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
    Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
    Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
    Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
    Shimizu C; Hasegawa T; Tani Y; Takahashi F; Takeuchi M; Watanabe T; Ando M; Katsumata N; Fujiwara Y
    Hum Pathol; 2004 Dec; 35(12):1537-42. PubMed ID: 15619214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
    Kornprat P; Rehak P; Rüschoff J; Langner C
    J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
    Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.
    Zhang X; Sun J; Wang H; Lou Y; Zhang Y; Sha H; Feng J; Han B
    Tumour Biol; 2014 Jan; 35(1):739-45. PubMed ID: 23990442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer.
    Köstler WJ; Hudelist G; Rabitsch W; Czerwenka K; Müller R; Singer CF; Zielinski CC
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):9-18. PubMed ID: 16184380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.